Prescription drug · ANDA
pimavanserin NDC 72205-055
Pimavanserin tartrate 34 mg/1 · Capsule · Oral · Novadoz Pharmaceuticals LLC
NDC codes
FDA NDC DirectoryProduct information
- Brand name (proprietary)
- pimavanserin
- Generic name (nonproprietary)
- pimavanserin
- Active ingredients
- Pimavanserin tartrate — 34 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Novadoz Pharmaceuticals LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214925
- Marketing start
- Listing expires
- Identifiers
- Product ID 72205-055_403b6540-c53d-4e92-91b4-36ca6338b2b1SPL ID 403b6540-c53d-4e92-91b4-36ca6338b2b1SPL set ID 403b6540-c53d-4e92-91b4-36ca6338b2b1RxCUI 2049275UNII NA83F1SJSRUPC 0372205055308
- Pharmacologic class
- Atypical Antipsychotic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Pimavanserin capsule is indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis [see Clinical Studies (14) ]. Pimavanserin capsule is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. (1)
Excerpt only. Read the full label for complete information.